EA201500700A1 - Иммуногенная композиция, содержащая антигены микоплазм - Google Patents

Иммуногенная композиция, содержащая антигены микоплазм

Info

Publication number
EA201500700A1
EA201500700A1 EA201500700A EA201500700A EA201500700A1 EA 201500700 A1 EA201500700 A1 EA 201500700A1 EA 201500700 A EA201500700 A EA 201500700A EA 201500700 A EA201500700 A EA 201500700A EA 201500700 A1 EA201500700 A1 EA 201500700A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antigens
immunogenic composition
composition containing
mycoplasm
mycoplasmic
Prior art date
Application number
EA201500700A
Other languages
English (en)
Other versions
EA038206B1 (ru
Inventor
Дайана М. Мёрфи Джордан
Брайан Томас Мартинсон
Кристине Маргарет Мьюленталер
Аксель Нойбауер
Арун В. Айер
Original Assignee
Бёрингер Ингельхайм Ветмедика Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Ветмедика Гмбх filed Critical Бёрингер Ингельхайм Ветмедика Гмбх
Publication of EA201500700A1 publication Critical patent/EA201500700A1/ru
Publication of EA038206B1 publication Critical patent/EA038206B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

В заявке описана иммуногенная композиция, содержащая: а) один или несколько антигенов М. hyorhinis и один или несколько антигенов М. hyosynoviae; и б) фармацевтически приемлемый носитель. Кроме того, в заявке описана иммуногенная композиция, которая содержит: а) один или несколько антигенов микоплазм из микоплазматических бактерий, выбранных из группы, состоящей из М. hyorhinis, M. hyopneumoniae и М. hyosynoviae; и б) один или несколько компонентов из системы на основе эукариотических клеток. Кроме того, в настоящей заявке описана иммуногенная композиция, полученная способом, заключающимся в том, что а) культивируют микоплазматические бактерии, выбранные из группы, состоящей из М. hyorhinis, M. hyopneumoniae и М. hyosynoviae, в системе на основе эукариотических клеток с пониженным содержанием сыворотки; б) получают антиген указанных микоплазматических бактерий и в) добавляют фармацевтически приемлемый носитель.
EA201500700A 2012-12-28 2013-12-20 Иммуногенная композиция, содержащая антигены микоплазм EA038206B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261747026P 2012-12-28 2012-12-28
PCT/US2013/076803 WO2014105671A1 (en) 2012-12-28 2013-12-20 Immunogenic composition comprising mycoplasma antigens

Publications (2)

Publication Number Publication Date
EA201500700A1 true EA201500700A1 (ru) 2016-01-29
EA038206B1 EA038206B1 (ru) 2021-07-23

Family

ID=49956440

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500700A EA038206B1 (ru) 2012-12-28 2013-12-20 Иммуногенная композиция, содержащая антигены микоплазм

Country Status (20)

Country Link
US (2) US9878027B2 (ru)
EP (2) EP3730148A3 (ru)
JP (2) JP6195630B2 (ru)
KR (1) KR102355614B1 (ru)
CN (2) CN104981252B (ru)
AR (1) AR094296A1 (ru)
AU (2) AU2013370982C9 (ru)
BR (1) BR112015015199B1 (ru)
CA (1) CA2896293C (ru)
CL (1) CL2015001659A1 (ru)
DK (1) DK2938356T3 (ru)
EA (1) EA038206B1 (ru)
ES (1) ES2808673T3 (ru)
MX (1) MX2015007729A (ru)
MY (1) MY174818A (ru)
PH (1) PH12015501335A1 (ru)
SG (1) SG11201505086QA (ru)
TW (1) TWI633890B (ru)
UA (1) UA121097C2 (ru)
WO (1) WO2014105671A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3730148A3 (en) * 2012-12-28 2021-03-24 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
SG11201505089YA (en) 2012-12-28 2015-07-30 Boehringer Ingelheim Vetmed Method of making a mycoplasma vaccine
CN104730256B (zh) * 2015-04-03 2016-05-04 江苏省农业科学院 用于检测支原体抗体的组合物及其应用
CN113444157B (zh) * 2021-06-23 2022-05-13 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0461在制备猪鼻支原体或其抗体检测试剂盒中的应用
CN113461791B (zh) * 2021-06-23 2022-05-03 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0493在制备猪鼻支原体或其抗体检测试剂盒中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
GB1074920A (en) 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production
GB1137306A (en) * 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS5540568B2 (ru) * 1972-10-05 1980-10-18
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US6537552B1 (en) * 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
KR100797547B1 (ko) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2003004051A2 (en) * 2001-07-02 2003-01-16 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
PL209773B1 (pl) * 2001-07-02 2011-10-31 Pfizer Prod Inc Zastosowanie bakteryny Mycoplasma hyopneumoniae do wytwarzania szczepionki
TWI238721B (en) * 2003-06-20 2005-09-01 Animal Technology Inst Taiwan Swine enzootic vaccine, its producing method and usage
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
JP2008529827A (ja) * 2005-02-09 2008-08-07 マグナ インターナショナル インコーポレイテッド 半構造的パネルの製造方法
CA2601006C (en) 2005-03-10 2012-10-23 Kyoritsu Seiyaku Corporation Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
MX2009002741A (es) * 2006-09-15 2009-05-11 Medimmune Llc Lineas de celulas mdck que soportan el crecimiento viral para altos titulos y proceso de biorreactor que utiliza las mismas.
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
CN101883581A (zh) 2007-11-06 2010-11-10 惠氏有限责任公司 猪肺炎支原体无毒力佐剂化活疫苗
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
JPWO2009142086A1 (ja) * 2008-05-23 2011-09-29 学校法人 久留米大学 マイコプラズマ感染症用ワクチン組成物
RU2510280C2 (ru) * 2008-06-27 2014-03-27 Пфайзер Инк. Новые адъювантные композиции
MX2011012362A (es) 2009-05-19 2012-04-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
WO2011075379A1 (en) * 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
AT509622A1 (de) * 2010-04-08 2011-10-15 Greiner Bio One Gmbh Verfahren und kit zur trennung viraler und prokaryontischer von eukaryontischen nukleinsäuren
CN102258776B (zh) 2011-07-07 2013-07-10 普莱柯生物工程股份有限公司 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
EP3730148A3 (en) * 2012-12-28 2021-03-24 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
SG11201505089YA (en) * 2012-12-28 2015-07-30 Boehringer Ingelheim Vetmed Method of making a mycoplasma vaccine
EP3049105B1 (en) * 2013-09-19 2020-12-30 Moredun Research Institute Vaccine
CA2943816A1 (en) * 2014-04-03 2015-10-08 Boehringer Ingelheim Vetmedica, Inc. Porcine epidemic diarrhea virus vaccine

Also Published As

Publication number Publication date
CN104981252B (zh) 2019-06-18
JP2017197568A (ja) 2017-11-02
AU2013370982C1 (en) 2019-01-17
KR20150100919A (ko) 2015-09-02
EP3730148A2 (en) 2020-10-28
CL2015001659A1 (es) 2016-09-16
PH12015501335A1 (en) 2015-09-02
DK2938356T3 (da) 2020-07-27
AU2018202698A1 (en) 2018-06-14
ES2808673T3 (es) 2021-03-01
JP2016505603A (ja) 2016-02-25
KR102355614B1 (ko) 2022-01-27
US20140186393A1 (en) 2014-07-03
JP6456437B2 (ja) 2019-01-23
EA038206B1 (ru) 2021-07-23
UA121097C2 (uk) 2020-04-10
EP2938356A1 (en) 2015-11-04
AU2013370982C9 (en) 2019-01-24
EP3730148A3 (en) 2021-03-24
MX2015007729A (es) 2015-09-07
CA2896293A1 (en) 2014-07-03
TWI633890B (zh) 2018-09-01
BR112015015199A2 (pt) 2017-07-11
EP2938356B1 (en) 2020-05-13
CN110227151B (zh) 2024-06-14
CA2896293C (en) 2023-11-07
TW201438733A (zh) 2014-10-16
CN104981252A (zh) 2015-10-14
BR112015015199B1 (pt) 2022-09-06
MY174818A (en) 2020-05-17
SG11201505086QA (en) 2015-07-30
AU2013370982B2 (en) 2018-02-15
US9878027B2 (en) 2018-01-30
CN110227151A (zh) 2019-09-13
AU2013370982A1 (en) 2014-07-03
AR094296A1 (es) 2015-07-22
WO2014105671A1 (en) 2014-07-03
AU2018202698B2 (en) 2020-02-13
JP6195630B2 (ja) 2017-09-13
US10758602B2 (en) 2020-09-01
US20180125957A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
EA201690492A1 (ru) Проникающие в клетку конъюгаты и способы их применения
PH12014502250B1 (en) Mycoplasma hyopneumoniae vaccine
EA201300915A1 (ru) Новый европейский штамм prrsv
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201400875A1 (ru) Антитела к cd47 и способы их применения
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112017026672A2 (pt) método de implantação de drx, método de configuração de drx e dispositivo relacionado
EA201500700A1 (ru) Иммуногенная композиция, содержащая антигены микоплазм
UY34656A (es) Polimorfos de (s)?2?(1?(9h?purin?6?ilamino)propil)?5?fluor?3?fenilquinazolin?4(3h)?ona, composición y método de preparación
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201500701A1 (ru) Способ создания вакцины против микоплазм
MY170720A (en) Antibody formulations
EA201300819A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
EA201390613A1 (ru) Обогащенный дейтерием расагилин
EA201391515A1 (ru) Инактивированная вакцина вируса денге
EA201592203A1 (ru) Способы лечения таупатии
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
EA201891124A3 (ru) Новые мукозные адъюванты и системы доставки
BR112012028711A2 (pt) métodos para a fabricação de uma emulsão de óleo em água, para a preparação de um kit de vacina e para redestilação de uma composição compreendendo 99% de esqualeno ou mais, assim como emulsão de óleo em água e kit
BR112014014319A2 (pt) composições de cuidado oral
EA201390467A1 (ru) Композиции антител и способы применения
BR112015020079A8 (pt) Composições para cuidado oral
BR112017024471A2 (pt) método e dispositivo para associar usuário com grupo
EA201590856A1 (ru) Получение живых вакцин